Growth Metrics

Jazz Pharmaceuticals (JAZZ) Enterprise Value Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.95%
Dec 31, 2025 42.31%
Sep 30, 2025 40.22%
Jun 30, 2025 12.24%
Mar 31, 2025 -29.00%
Dec 31, 2024 -60.18%
Sep 30, 2024 -66.07%
Jun 30, 2024 -5.73%
Mar 31, 2024 -23.59%
Dec 31, 2023 -70.88%
Sep 30, 2023 -59.13%
Jun 30, 2023 -80.28%
Mar 31, 2023 -137.94%
Dec 31, 2022 -49.04%
Sep 30, 2022 -24.95%
Jun 30, 2022 20.21%
Mar 31, 2022 76.60%
Dec 31, 2021 44.09%
Sep 30, 2021 9.46%
Jun 30, 2021 -13.40%
Mar 31, 2021 -198.96%
Dec 31, 2020 -65.97%
Sep 30, 2020 6.69%
Jun 30, 2020 -23.26%
Mar 31, 2020 -28.15%
Dec 31, 2019 -105.85%
Sep 30, 2019 -59.35%
Jun 30, 2019 -31.47%
Mar 31, 2019 -20.81%
Dec 31, 2018 19.79%
Sep 30, 2018 -10.25%
Jun 30, 2018 -51.96%
Mar 31, 2018 -11.35%
Dec 31, 2017 9.37%
Sep 30, 2017 -6.25%
Jun 30, 2017 65.17%
Mar 31, 2017 58.49%
Dec 31, 2016 56.92%
Sep 30, 2016 57.35%
Jun 30, 2016 0.57%
Mar 31, 2016 -25.30%
Dec 31, 2015 -44.56%
Sep 30, 2015 -73.73%
Jun 30, 2015 -244.06%
Mar 31, 2015 -242.83%
Dec 31, 2014 -7.46%
Sep 30, 2014 2.30%
Jun 30, 2014 46.89%
Mar 31, 2014 49.33%
Dec 31, 2013 -64.39%
Sep 30, 2013 -210.05%
Jun 30, 2013 -226.32%
Mar 31, 2013 -84.47%
Dec 31, 2012 -145.22%
Sep 30, 2012 -67.44%
Jun 30, 2012 -50.93%
Mar 31, 2012 -275.37%
Dec 31, 2011 -252.50%
Sep 30, 2011 -395.99%
Jun 30, 2011 -969.52%